Geneva Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Geneva Advisors's PFE Position: Q2 2017 in Review
Geneva Advisors increased its Pfizer (PFE) stake by 0.45% in Q2 2017, buying an estimated $31.1K and bringing the position to 218,939 shares worth $6.98M. The position accounts for 0.12% of the portfolio, ranked #107.
Geneva Advisors first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $7.39M in Q3 2016. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- Geneva Advisors held 218,939 shares of Pfizer worth $6.98M as of Q2 2017.
- Geneva Advisors bought 986 Pfizer shares in Q2 2017, an estimated $31.1K.
- Pfizer made up 0.12% of Geneva Advisors's portfolio in Q2 2017, its #107 holding.
- Geneva Advisors first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
- Geneva Advisors's Pfizer position peaked at $7.39M in Q3 2016.
- 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.